Oncopeptides publishes Q2 report 2022 - Press Release

STOCKHOLM, Aug. 11, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a biotech company focused on research and development of the

Related Keywords

Sweden ,Stockholm ,United Kingdom ,Swedish ,Oncopeptides Pepaxti ,Annika Muskantor ,Rolf Gulliksen ,Klaas Bakker ,Jakob Lindberg ,Committee For Medicinal Products Human ,Oncologic Drugs Advisory Committee ,European Commission ,European Medicines Agency ,Global Head Of Corporate Communications ,Nasdaq ,Medicinal Products ,Human Use ,Global Head ,Corporate Communications ,Swedish Financial Instruments Trading Act ,Mid Cap ,Nasdaq Stockholm ,